Combination vaccines okay for infants, study shows

Oct 03, 2007

A University of Rochester study brings relief to new parents who, while navigating a jam-packed childhood vaccine schedule, can expect to soothe their newborn through as many as 15 “pokes” by his or her six-month checkup.

The study, recently published in The Journal of Pediatrics, shows that no efficacy or safety is compromised when clinicians administer a new combination vaccine that streamlines the process – in effect, tripling up three of the recommended shots to reduce the “poke” total from five to three, at each of three bimonthly, well-child checkups.

“Only more immunizations will enter the schedule,” said Michael Pichichero, M.D., professor of Microbiology/Immunology, Pediatrics and Medicine at the University of Rochester and the study’s lead author. “Coupling or tripling of these vaccines is increasingly important, as this streamlining helps to promote parent compliance, timely vaccination and fewer administration errors.”

The study overturns findings (and fears) from a previous study that suggested problems when two specific vaccines were given at the same time – Pediarix, a combination of vaccines that guard against diphtheria, tetanus, whooping cough, hepatitis B and poliovirus, and Prevnar, which protects against 76 strains of Streptococcus pneumonia. The earlier studies found that when the vaccines were co-administered, a suboptimal immune response was produced against whooping cough, and more uncomfortable reactions, such as swelling at the injection site, could be expected.

Both Pediarix and Prevnar are recommended for administration at 2-, 4- and 6-month checkups; Prevnar was approved in 2000, shortly before the licensure of Pediarix.

“This newest study unseated both early reservations, showing that the combination vaccine was in fact just as safe and as immunogenic as separate shots, even in the midst of other vaccines in the schedule,” Pichichero said.

Study Details

A total of 575 healthy 2-month-olds were enrolled at 22 sites nationwide. Each infant was randomly assigned to one of three trial groups:

1. Combination Vaccine Group, which received three vaccines – the combination vaccine (DTaP-HepB-IPV, or brand name Pediarix), a second vaccine to protect against HiB, and a third, PCV-7 (or brand name Prevnar).

2. Separate Vaccine Group, which received five independent vaccines: DTaP, (for diphtheria, tetanus and whooping cough), HepB (for hepatitis B), IPV (for poliovirus), HiB, and PVC-7.

3. Staggered Vaccine Group that was identical to the Combination Group, save that PCV-7 vaccines were delayed by two weeks at every appointment, thereby demanding a total of six pediatric office visits, instead of three.

Blood samples were collected before the study began, and again when infants were 7 months, to test for a robust immune response to each disease-trigger.

Parents were provided a diary and asked to record temperatures, general symptoms such as fussiness, irritability or loss of appetite, and local injection site symptoms such as pain or swelling.

Results

Minor symptoms were more common in the Combination Vaccine Group; however higher fevers and more severe shot site reactions were not significantly more likely to occur in infants in any of the three groups.

For example, swelling and pain were significantly higher at the injection site of the combination vaccine, but Pichichero said that is to be expected, given that there are more ingredients in that single shot (vaccines are made from killed or modified forms of bacteria or viruses, or only pieces or products of the germs). But, he added, it was noteworthy that at no time did any local symptoms (swelling, redness, pain) lead to an infant obtaining a medical attention visit.

“Vaccine opponents may liken the process of the body processing simultaneous vaccines to a computer running too many applications; the machine grows slow, and the programs, one by one, begin to terminate,” Pichichero said. “But those fears are unfounded; we have found no evidence that a child’s body is at any point approaching a maximum threshold as far as learning to produce immune responses.”

When you administer more vaccines, you expect more symptoms, more fevers, he said. Fever, swelling, redness are all indicators that the vaccine is working, that the body is busy creating the right immunity to prevent disease.

“So long as they are mild, they pale in comparison to benefits of convenience to the parent, the fewer number of pokes to the infant, and of course, the severity of the diseases we are preventing,” he said.

Perhaps most importantly, the study showed the Combination Vaccine Group enjoyed at least as good immunogenicity as the Separate and Staggered Groups, for all criteria – including the criterion for protecting against whooping cough, for which previous, smaller-scale studies had yielded inconsistent results.

“If pediatricians were holding out on making the switch to a combined vaccine for fear that its protection might be inferior, they no longer need be concerned,” Pichichero said. “It seems the clinical relevance of any previously observed differences with regard to whooping cough immunity have been dispelled.”

Source: University of Rochester Medical Center

Explore further: Study recalculates costs of combination vaccines

add to favorites email to friend print save as pdf

Related Stories

First metritis vaccine protects dairy cows

Apr 15, 2014

(Phys.org) —Cornell scientists have created the first vaccines that can prevent metritis, one of the most common cattle diseases. The infection not only harms animals and farmers' profits, but also drives ...

Polymer microparticles could help verify goods

Apr 13, 2014

Some 2 to 5 percent of all international trade involves counterfeit goods, according to a 2013 United Nations report. These illicit products—which include electronics, automotive and aircraft parts, pharmaceuticals, ...

NASA to conduct unprecedented twin experiment

Apr 11, 2014

Consider a pair of brothers, identical twins. One gets a job as an astronaut and rockets into space. The other gets a job as an astronaut, too, but on this occasion he decides to stay home. After a year ...

Climate change as a matter of public health

Apr 08, 2014

For a long time people perceived climate change as an environmental issue–the concern of environmentalists, the concern of a few. It was reframed as a justice issue at the turn of the 21st century, when ...

Climate conditions help forecast meningitis outbreaks

Mar 18, 2014

Determining the role of climate in the spread of certain diseases can assist health officials in "forecasting" epidemics. New research on meningitis incidence in sub-Saharan Africa pinpoints wind and dust ...

3D scans map widespread fish disease

Mar 05, 2014

Seventy-five per cent of antibiotics in Danish fish farms is used to treat fish with enteric redmouth disease. With the help of 3D scans, researchers at the University of Copenhagen have mapped how the fish are infected with ...

Recommended for you

Study recalculates costs of combination vaccines

1 hour ago

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

4 hours ago

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Pyridoxine-doxylamine drug safety data lacking

Apr 16, 2014

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

tswogger
not rated yet Nov 01, 2007
when Pichichero says "it seems the clinical relevance of any previously observed differences with regard to whooping cough immunity have been dispelled." I'm interested to know how clinical relevance was determined....I mean whooping cough is something that affect children up until adulthood, so in order to truly study the "clinical" relevance, this study would have to follow children in both vaccine groups until adulthood and then compare rates of infection with whooping cough between groups, correct??

More news stories

Study recalculates costs of combination vaccines

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Researchers discover target for treating dengue fever

Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other ...

Hackathon team's GoogolPlex gives Siri extra powers

(Phys.org) —Four freshmen at the University of Pennsylvania have taken Apple's personal assistant Siri to behave as a graduate-level executive assistant which, when asked, is capable of adjusting the temperature ...

Better thermal-imaging lens from waste sulfur

Sulfur left over from refining fossil fuels can be transformed into cheap, lightweight, plastic lenses for infrared devices, including night-vision goggles, a University of Arizona-led international team ...